Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lexicon Pharmaceutcl (NQ: LXRX )

1.940 -0.010 (-0.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,880,383
Open 1.970
Bid (Size) 1.930 (2)
Ask (Size) 1.940 (50)
Prev. Close 1.950
Today's Range 1.860 - 1.985
52wk Range 0.9200 - 3.730
Shares Outstanding 144,474,452
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Peeling Back The Layers: Exploring Lexicon Pharmaceuticals Through Analyst Insights
Via Benzinga
Beyond The Numbers: 7 Analysts Discuss Lexicon Pharmaceuticals Stock
Via Benzinga

Performance

YTD
+22.01%
+22.01%
1 Month
+22.78%
+22.78%
3 Month
-12.61%
-12.61%
6 Month
+20.50%
+20.50%
1 Year
+77.98%
+77.98%

More News

Read More
The Analyst Verdict: Lexicon Pharmaceuticals In The Eyes Of 8 Experts
Via Benzinga
Analyst Scoreboard: 6 Ratings For Lexicon Pharmaceuticals
Via Benzinga
5 Analysts Have This To Say About Lexicon Pharmaceuticals
Via Benzinga
Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Lexicon Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
Intel Reports Weak Results, Joins Amazon, Opendoor Technologies And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Aaron's, Nvidia, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday
Via Benzinga
Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
Via Investor's Business Daily
LXRX Stock Earnings: Lexicon Pharmaceuticals Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
Via Benzinga
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Dow Turns Higher; GDS Holdings Shares Climb
Via Benzinga
Topics Stocks
Exposures US Equities
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Exposures Product Safety
Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Top 4 Health Care Stocks You May Want To Dump In February
Via Benzinga
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts
Via The Motley Fool
3 of the Fastest-Growing Stocks on the Planet in 2024
Via The Motley Fool
7 Magnificent Stocks That Can Double Your Money in 2024
Via The Motley Fool
3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.